APAC Blood Glucose Monitoring Devices Market Share, Trends, Revenue, Growth Drivers, Challenges, Key Players and Future Investment Strategies Till 2033


APAC Blood Glucose Monitoring Devices Market Share, Trends, Revenue, Growth Drivers, Challenges, Key Players and Future Investment Strategies Till 2033: SPER Market Research

 Category : Medical Devices

 Published: Feb-2024
 Author: SPER Analyst

Asia-Pacific Blood Glucose Monitoring Market is projected to be worth USD 7.53 billion by 2033 and is anticipated to surge at a CAGR of 7.98%.

Blood glucose monitoring devices are used to measure blood glucose levels in diabetic people and to control their diabetes. Patients can easily and non-invasively check their blood glucose levels with the use of these devices. The devices perform a quantitative test and provide information about blood glucose levels. By keeping an eye on blood glucose levels and getting medical assistance when needed, it helps people manage the illness.

Asia-Pacific Blood Glucose Monitoring Market Driving Factors and Challenges

Drivers: Type 1 and Type 2 diabetes are becoming more and more common in newly diagnosed cases, primarily due to obesity, poor food, and inactivity. The rise in healthcare spending and the number of diabetes patients is indicative of the growing use of diabetic care products in developed nations. Additionally, the growing prevalence of diabetes and the growing use of insulin delivery devices are factors driving market expansion. Leading manufacturers are putting an emphasis on technological advancements and the development of novel products in order to secure a significant portion of the market. These factors are expected to cause the market under examination to grow over the course of the investigation.

Challenges: Numerous challenges impede the growth and development of the blood glucose monitoring market in Asia-Pacific. The diverse economic contexts in the area lead to varying levels of healthcare infrastructure and accessibility, which is a significant obstacle. It could be challenging for less developed countries to adopt state-of-the-art blood glucose monitoring equipment, which would hinder its market penetration. Furthermore, differences in healthcare regulations and cultural backgrounds impede the standardization and seamless integration of blood glucose monitoring solutions. The accessibility of counterfeit goods is a noteworthy concern that requires attention as it has the potential to manipulate blood glucose testing and negatively impact patient outcomes.

Impact of COVID-19 on Asia-Pacific Blood Glucose Monitoring Market
The pandemic of COVID-19 helps the Asia-Pacific Diabetes Care Devices Market expand. COVID-19-positive people with diabetes may have abnormal glucose swings, increased blood glucose levels, and other diabetes-related issues. Individuals with diabetes, particularly those with poor glycemic control and type 1 (T1DM) or type 2 (T2DM) diabetes mellitus, had a significant increase in the severity and mortality of COVID-19. Moreover, the onset of hyperglycemia and diabetes (T1DM and T2DM) has been linked to worse outcomes and has been observed more frequently in the COVID-19 setting.

Asia-Pacific Blood Glucose Monitoring Market Key Players:
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players are; Abbott Diabetes Care, Acon, Agamatrix Inc., Arkray, Ascensia Diabetes Care, Bionime Corporation, Dexcom, Johnson and Johnson (Lifescan), Medisana, Medtronic, Roche, Rossmax, Others.

Asia-Pacific Blood Glucose Monitoring Market Segmentation:

By Self-monitoring Blood Glucose Devices: Based on the Self-monitoring Blood Glucose Devices, Asia-Pacific Blood Glucose Monitoring Market is segmented as; Glucometer Devices, Test Strips, Lancets.

By Continuous Glucose Monitoring Devices: Based on the Continuous Glucose Monitoring Devices, Asia-Pacific Blood Glucose Monitoring Market is segmented as; Sensors, Durables.

By End User: Based on the End User, Asia-Pacific Blood Glucose Monitoring Market is segmented as; Hospital/Clinics, Home/Personal.

By Region: This research also includes data for China, Japan, Australia, India, Rest of Asia Pacific.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Johnson & Johnson


Market Research

We are the leading, full-service global market research and consulting company.

iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]